Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | BKCa channels: potential novel anti-migraine target

Messoud Ashina • 29 May 2020
EAN 2020
Headache

Messoud Ashina, MD, PhD, DMSc, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, discusses whether direct Large-conductance calcium-activated potassium (BKCa) channel activation can provoke migraine in migraine patients, and whether the BKCa channel could be a potential novel target for its treatment.. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Messoud Ashina

2:43
The burden of migraine: from individuals to society
Messoud Ashina • 23 Jun 2022
1:47
Anti-CGRP monoclonal antibodies for difficult to treat migraines: DELIVER trial
Messoud Ashina • 23 Jun 2022
3:04
PACAP as a future target for anti-migraine medication
Messoud Ashina • 23 Jun 2022
3:19
Real-world studies show effectiveness of anti-CGRP mAbs in difficult to treat patients with migraine
Messoud Ashina • 23 Jun 2022

Related Videos

3:35
Promising targets in headache research: PACAP
Alan Rapoport • 22 Mar 2024
2:03
What follow-up care is needed for patients with medication overuse headache?
Alan Rapoport • 22 Mar 2024
2:59
Medication overuse headache: current strategies and unmet needs
Morris Levin • 22 Mar 2024
1:26
The potential applications of AI in headache medicine
Morris Levin • 22 Mar 2024
The content of VJNeurology is intended for healthcare professionals